Phase III trial: Trabectedin shows benefit in advanced ovarian cancer
Submitted by Anonymous on Thu, 2008-09-18 12:20
Phase III trial: Trabectedin shows new benefit in advanced ovarian cancer
User login
Links we like
Medical news and content
ASH Press Releases
Bloomberg Health
Cardiology Today
digg.com Health
EurekAlert!
FDA-CDER
FDA-New Drug Approvals
FDA-Press Room
Google Health
Healthfinder.gov
Health News Review
HemOncToday
NHS Behind the Headlines
NYT Health
NYT Science
Ob.Gyn. News
Oncology Times
PipelineReview
PLoS ONE
PubMed
Johns Hopkins
Bloomberg Health
Cardiology Today
digg.com Health
EurekAlert!
FDA-CDER
FDA-New Drug Approvals
FDA-Press Room
Google Health
Healthfinder.gov
Health News Review
HemOncToday
NHS Behind the Headlines
NYT Health
NYT Science
Ob.Gyn. News
Oncology Times
PipelineReview
PLoS ONE
PubMed
Johns Hopkins
Blogs
Journals
Annals Internal Medicine
Blood
Cancer research
Haematologica (free!)
JAMA
JCO
JNCI
Journal Watch
Lancet
Lancet Oncology
Nature
NEJM
PLoS Medicine
Proceedings of the National Academy of Sciences
Science
Annals Internal Medicine
Blood
Cancer research
Haematologica (free!)
JAMA
JCO
JNCI
Journal Watch
Lancet
Lancet Oncology
Nature
NEJM
PLoS Medicine
Proceedings of the National Academy of Sciences
Science
Others
Check out the InteractMD.com podcast!
66126 visitors
66126 visitors
Dr. Michael Kirsch of MDWhistleblower now podcasting!
54055 visitors
54055 visitors
Similar
- Phase III trial: Trabectedin shows benefit in advanced ovarian cancer
- Bevacizumab plus sorafenib promising for ovarian cancer
- Study: Hormone replacement therapy increases ovarian cancer risk
- Herceptin scores solid base hit in gastric cancer--ASCO report
- Further data on Alimta (pemetrexed) in ovarian cancer
Popular content
Today's:
- Ear candles...yes, ear candles
- Smokers with lung cancer: quit now and live longer, says new study
- Scientists find specially tailored music treats tinnitus
- Pfizer seeks FDA clearance for Sutent in rare pancreatic malignancy
- Warfarin pharmacogenetic testing not cost effective despite Medco's efforts to dictate care
All time:
Last viewed:
- Long term results: FCR very effective initial therapy for CLL
- Athletes turn to a new form of blood treatment--platelet rich plasma--to heal battered ligaments and tendons
- Drug company: Pixantrone effective safe for advanced lymphoma
- About InteractMD.com
- Phase III trial: Chemo improves local control in preop rectal cancer
Who's online
There are currently 0 users and 4 guests online.